Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical™ solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics.
T cells can be used to identify type 1 diabetes risk, study shows
Scripps Research scientists have shown that analyzing a certain type of immune cell in the blood can help identify people at risk of developing type
July 20, 2023